James Garner

James Garner

Company: Kazia therapeutics

Job title: Chief Executive Officer & Managing Director

Seminars:

Live Q&A – Ask the Speakers Your Burning Questions 6:30 pm

Read more

day: Day One

Developing a PI3K Inhibitor for Brain Cancer – What We Have Learned 5:30 pm

Rationale for PI3K inhibitors in brain cancer and the challenge of the blood-brain barrier Identification of optimal target populations and the significance of PI3K biomarkers Perspectives on combination strategies and management of toxicitiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.